MENU
NRIX
AS OF
Feb 4, 03:07 PM (EDT)
Price
$16.13
Change
-$0.66 (-3.93%)
Capitalization
1.73B
69 days until earnings call
Intraday BUY SELL Signals
NRIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nurix Therapeutics (NRIX) Earnings Date & Reports

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders... Show more

A.I. Advisor
published Earnings

NRIX is expected to report earnings to rise 5.59% to -86 cents per share on April 14

Nurix Therapeutics NRIX Stock Earnings Reports
Q1'26
Est.
$-0.87
Q4'25
Beat
by $0.10
Q3'25
Missed
by $0.20
Q2'25
Beat
by $0.19
Q1'25
Beat
by $0.09
The last earnings report on January 28 showed earnings per share of -81 cents, beating the estimate of -92 cents. With 85.91K shares outstanding, the current market capitalization sits at 1.73B.
View a ticker or compare two or three
NRIX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NRIX showed earnings on January 28, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1700 Owens Street
Phone
+1 415 660-5320
Employees
284
Web
http://www.nurixtx.com